Inovio Pharmaceuticals Inc. (INO:NASDAQ) has expanded the Phase 1 trial of its Ebola vaccine to include an additional 125 healthy subjects. This … Full Article http://j.gs/5sTq
Click here to read full articleInovio Pharmaceuticals Inc. (INO:NASDAQ) has expanded the Phase 1 trial of its Ebola vaccine to include an additional 125 healthy subjects. This … Full Article http://j.gs/5sTq
Click here to read full article
No comments:
Post a Comment